WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2025 Issue has been successfully launched on 1 NOVEMBER 2025.

Abstract

DEVELOPMENT AND CHARACTERIZATION OF SUSTAINED RELEASE MATRIX TABLET OF LOSARTAN POTASSIUM

Nikki Tripathi* and Dr. Shiv Garg

ABSTRACT

The objective of the present work was to design, formulate and evaluate Losartan Potassium sustained release dosage form by incorporating it in a sustained release matrix made up of release retardant polymers which will prolong the drug release leading to minimize the peak and valley effect in the plasma and provide patient convenience. In the present study a total number of nine formulations each containing 50 mg of Losartan Potassium were prepared using wet granulation technique. All the nine formulations were subjected to in vitro dissolution studies using USP XXIII dissolution tester. Percentage cumulative drug release of drug in each formulation was determined based on the drug content uniformity. Formulation S3 best formulation because the maximum drug release was observed in S3 (95.1%) Formulation up to 20 hrs. Formulation S3 combinationshowed maximum swelling compared other formulation. The compatibility of the drug, polymers and excipients was determined by I.R. spectroscopy. Results showed that the drugs are compatible with polymers and all excipients. The granules were subjected to pre-compression evaluation such as angle of repose, loose bulk density, tapped bulk density and compressibility index. It was concluded that granules exhibited good compressibility and flow property. The tablets were subjected to various evaluation parameters such as thickness and diameter tests, weight variation test, hardness test, friability test, and drug content uniformity test. The results for all above evaluation parameters indicate that the values are within the range. Formulation S1-S9 showed zero order kinetics. Formulation S3 best formulation because the maximum drug release was observed in S3 (95.1%) Formulation up to 20 hrs and Formulation S3 combination showed maximum swelling compared other formulation.

Keywords: Drug, Pharmacokinetics, Evaluation, Sustained release, Diffusion.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More